Published in J Antimicrob Chemother on May 01, 1996
MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother (2003) 1.58
Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model. Antimicrob Agents Chemother (1997) 1.04
Potentiation of Aminoglycoside Activity in Pseudomonas aeruginosa by Targeting the AmgRS Envelope Stress-Responsive Two-Component System. Antimicrob Agents Chemother (2016) 0.75
Pasteurella multocida bacteremia: report of thirteen cases over twelve years and review of the literature. Scand J Infect Dis (1987) 2.47
Why is antimicrobial de-escalation under-prescribed for urinary tract infections? Infection (2012) 2.04
Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase. Antimicrob Agents Chemother (1990) 1.96
[Antibiogram Committee of the French Microbiology Society. Report 2000-2001]. Pathol Biol (Paris) (2000) 1.94
Partial purification and properties of the Epstein-Barr virus-associated nuclear antigen. J Biol Chem (1978) 1.85
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500. Antimicrob Agents Chemother (1995) 1.63
Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat Genet (1999) 1.62
Plasma levels and therapeutic response with trimipramine treatment of endogenous depression. J Clin Psychiatry (1988) 1.51
Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb Ecol (2008) 1.51
The HLA B27 antigen-spondylarthropathy association. Impact on clinical expression. Rev Rhum Engl Ed (1996) 1.44
Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum (2001) 1.44
Prognostic factors in acute cardiogenic pulmonary edema. Am J Emerg Med (1999) 1.39
[Primary staphylococcal septicemia in adults. A retrospective study]. Presse Med (1989) 1.39
Evaluation of indium-111-labeled antifibrin monoclonal antibody for the diagnosis of venous thrombotic disease. J Nucl Med (1991) 1.39
The antiperinuclear factor in spondylarthropathies. Br J Rheumatol (1995) 1.39
[Role of invasive technics in the occurrence of nosocomial infections. At an intensive care unit]. Presse Med (1989) 1.39
[Appropriate use of antibiotics in hospitals. Investigating clinical practices in management of community-acquired pneumonia]. Presse Med (2005) 1.39
A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med (1987) 1.32
Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis. Antimicrob Agents Chemother (1989) 1.27
Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis (2013) 1.27
Quality of life survey of urinary diversion patients: comparison of ileal conduits versus continent Kock ileal reservoirs. J Urol (1987) 1.18
Comparative study of methods of measuring acute pain intensity in an ED. Am J Emerg Med (1998) 1.17
Unique B cell differentiation profile in tolerant kidney transplant patients. Am J Transplant (2013) 1.14
Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator. Circulation (1988) 1.12
Intrauterine infection induces programmed cell death in rabbit periventricular white matter. Pediatr Res (2000) 1.12
Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man. Cardiovasc Res (1986) 1.11
In vivo simulation of human pharmacokinetics in the rabbit. Bull Math Biol (1998) 1.08
Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol (2001) 1.08
Significance of Propionibacterium acnes-positive samples in spinal instrumentation. Spine (Phila Pa 1976) (2008) 1.05
Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model. Antimicrob Agents Chemother (1997) 1.04
Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis. Int J Antimicrob Agents (2010) 1.04
Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model. Antimicrob Agents Chemother (1994) 1.04
Lung distribution and pharmacokinetics of aerosolized tobramycin. Am Rev Respir Dis (1993) 1.03
Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications. Aliment Pharmacol Ther (2014) 1.03
Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. J Vet Pharmacol Ther (1995) 1.02
Isolation of Bacteroides strains with reduced sensitivity to 5-nitroimidazoles. Eur J Clin Microbiol (1986) 1.02
The impact of a family planning multimedia campaign in Bamako, Mali. Stud Fam Plann (1998) 0.97
Recurrent pneumonia due to rifampicin-resistant Rhodococcus equi in a patient infected with HIV. J Infect (1992) 0.95
Dynamics of ceftazidime-pefloxacin interaction shown by a new killing curve-chequerboard method. J Antimicrob Chemother (1987) 0.95
Influence of isostatic compression on the stability of vancomycin loaded with a calcium phosphate-implantable drug delivery device. J Biomed Mater Res (2000) 0.95
Assessment of formulas for calculating critical concentration by the agar diffusion method. Antimicrob Agents Chemother (1987) 0.93
In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model. J Antimicrob Chemother (2001) 0.93
The use of Doppler flow studies in the diagnosis of giant cell arteritis. Selection of temporal artery biopsy site is facilitated. JAMA (1982) 0.92
Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1996) 0.92
Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis. Antimicrob Agents Chemother (1992) 0.92
Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects. Antimicrob Agents Chemother (1996) 0.92
[Studies on the arsenic-induced changes of the nucleic acid synthesis in vitro]. Dermatol Monatsschr (1974) 0.91
Spectroscopic evidence for the formation of a 4-keto intermediate in the UDP-apiose/UDP-xylose synthase reaction. Eur J Biochem (1975) 0.91
Long-term evolution of a nosocomial outbreak of Pseudomonas aeruginosa producing VIM-2 metallo-enzyme. J Hosp Infect (2008) 0.90
Emergence of carbapenem-hydrolysing metallo-beta-lactamase VIM-1 in Pseudomonas aeruginosa isolates in France. Clin Microbiol Infect (2006) 0.90
[Arsenic-dependent changes in nucleic acid synthesis in human lymphocytes obtained by sedimentation or Ficoll gradient (author's transl)]. Arch Dermatol Forsch (1974) 0.90
Effects of arsenic cell metabolism and cell proliferation: cytogenetic and biochemical studies. Environ Health Perspect (1977) 0.90
Patterns of cerebral inflammatory response in a rabbit model of intrauterine infection-mediated brain lesion. Brain Res Dev Brain Res (2003) 0.90
Factors predicting radical treatment after in-hospital conservative management of disk-related sciatica. Joint Bone Spine (2001) 0.89
Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation. Antimicrob Agents Chemother (1991) 0.88
Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease. Am J Clin Nutr (2001) 0.88
[Comparison of the bactericidal activity of three aminosides: gentamicin, tobramycin and amikacin]. Pathol Biol (Paris) (1987) 0.88
A case of biliary tract infection caused by Haemophilus parainfluenzae. Eur J Clin Microbiol Infect Dis (1992) 0.87
Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients. Intensive Care Med (1993) 0.87
Clinical, laboratory, and radiographic features of rheumatoid arthritis with and without nodules. Rev Rhum Engl Ed (1997) 0.87
In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study. Clin Microbiol Infect (2003) 0.86
[Inclusion of a rapid test in the current Health Ministry Guidelines with the purpose of improving anti-tetanus prophylaxis prescribed to wounded patients presenting at French Emergency Departments]. Med Mal Infect (2005) 0.86
Actinomycosis of the gallbladder due to Actinomyces naeslundii. J Infect (1987) 0.86
Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis (1987) 0.84
Purification and properties of an enzyme from cell suspension cultures of parsley catalyzing the synthesis of UDP-apiose and UDP-D-xylose from UDP-D-glucuronic acid. Biochim Biophys Acta (1972) 0.84
A delivery system of linezolid to enhance the MRSA osteomyelitis prognosis: in vivo experimental assessment. Eur J Clin Microbiol Infect Dis (2012) 0.84
The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families. Hum Mutat (2000) 0.84
[Prior use of anti-inflammatory and antibiotic drugs in patients hospitalized for peritonsillar abscess]. Med Mal Infect (2009) 0.84
Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model. Antimicrob Agents Chemother (2002) 0.83
Further in vitro studies on the biochemistry of the inhibition of nucleic acid and protein synthesis induced by arsenic. Arch Dermatol Res (1975) 0.83
[Osteoporosis during pregnancy. 4 cases]. Rev Rhum Ed Fr (1993) 0.83
Almond oil implicated in a Staphylococcus capitis outbreak in a neonatal intensive care unit. J Perinatol (2007) 0.83
Therapeutic amoxicillin levels achieved with oral administration in term neonates. Eur J Clin Pharmacol (2007) 0.83
In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model. Antimicrob Agents Chemother (1996) 0.82